Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;42(6):736-743.
doi: 10.1002/pd.6145. Epub 2022 Apr 20.

Fetal central nervous system anomalies: When should we offer exome sequencing?

Caitlin Baptiste  1 , Rhiannon Mellis  2 , Vimla Aggarwal  1 , Jenny Lord  3 , Ruth Eberhardt  4 , Mark D Kilby  5   6 , Eamonn R Maher  7 , Ronald Wapner  8 , Jessica Giordano  9 , Lyn Chitty  2
Affiliations
Review

Fetal central nervous system anomalies: When should we offer exome sequencing?

Caitlin Baptiste et al. Prenat Diagn. 2022 May.

Abstract

Objective: To investigate the detection of pathogenic variants using exome sequencing in an international cohort of fetuses with central nervous system (CNS) anomalies.

Methods: We reviewed trio exome sequencing (ES) results for two previously reported unselected cohorts (Prenatal Assessment of Genomes and Exomes (PAGE) and CUIMC) to identify fetuses with CNS anomalies with unremarkable karyotypes and chromosomal microarrays. Variants were classified according to ACMG guidelines and association of pathogenic variants with specific types of CNS anomalies explored.

Results: ES was performed in 268 pregnancies with a CNS anomaly identified using prenatal ultrasound. Of those with an isolated, single, CNS anomaly, 7/97 (7.2%) had a likely pathogenic/pathogenic (LP/P) variant. This includes 3/23 (13%) fetuses with isolated mild ventriculomegaly and 3/10 (30%) fetuses with isolated agenesis of the corpus callosum. Where there were multiple anomalies within the CNS, 12/63 (19%) had LP/P variants. Of the 108 cases with CNS and other organ system anomalies, 18 (16.7%) had LP/P findings.

Conclusion: ES is an important tool in the prenatal evaluation of fetuses with any CNS anomaly. The rate of LP/P variants tends to be highest in fetuses with multiple CNS anomalies and multisystem anomalies, however, ES may also be of benefit for isolated CNS anomalies.

PubMed Disclaimer

References

REFERENCES

    1. Van den Veyver IB. Prenatally diagnosed developmental abnormalities of the central nervous system and genetic syndromes: a practical review. Prenat Diagn. 2019;39:666-678.
    1. Van Zalen-Sprock MM, Van Vugt JM, Karsdorp VH, Maas R, van Geijn HP. Ultrasound diagnosis of fetal abnormalities and cytogenetic evaluation. Prenat Diagn. 1991;11:655-660.
    1. Nicolaides KH, Snijders RJ, Gosden CM, Gosden CM, Berry C. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet. 1992;340(8821):704-707.
    1. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367:2175-2184.
    1. Best S, Wou K, Vora N, Van derVeyver IB, Wapner R, Chitty LS. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn. 2018;38:10-19.

LinkOut - more resources